TKNO
Alpha Teknova, Inc.
+0.21 (+2.95%)7.32USD127K成交股數393M市值–本益比(近四季)9.0股價營收比+18.4%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 12.2M+18% | 11.1M+13% | 10.0M+4% | 10.5M+9% | 10.3M+11% | 9.8M+25% | 9.6M+17% | 9.6M-17% | 9.3M | 7.9M | 8.2M | 11.5M |
| 營業成本 | 7.3M | 7.3M | 6.7M | 7.2M | 6.3M | 6.8M | 9.5M | 6.8M | 7.1M | 6.5M | 6.7M | 6.5M |
| 毛利 | 4.9M+23% | 3.8M+26% | 3.2M+3504% | 3.2M+14% | 4.0M+80% | 3.0M+125% | 90K-94% | 2.8M-45% | 2.2M | 1.3M | 1.5M | 5.1M |
| 毛利率 | 40.1% | 34.2% | 32.5% | 30.7% | 38.7% | 30.7% | 0.9% | 29.2% | 23.8% | 17.0% | 18.0% | 43.9% |
| 研發費用 | 554K | 609K | 522K | 542K | 581K | 552K | 627K | 678K | 860K | 1.3M | 1.4M | 1.5M |
| 銷售管理費用 | 4.8M | 5.1M | 5.3M | 4.6M | 4.9M | 5.5M | 5.0M | 5.5M | 7.4M | 6.0M | 6.1M | 5.9M |
| 營業利益 | −2.9M-15% | −4.3M-13% | −4.6M-38% | −4.0M-21% | −3.4M-58% | −5.0M-54% | −7.4M-15% | −5.1M-27% | −8.0M | −10.9M | −8.8M | −7.0M |
| 營業利益率 | -23.7% | -38.8% | -46.2% | -38.4% | -32.9% | -50.7% | -77.6% | -53.0% | -86.0% | -138.0% | -107.3% | -60.7% |
| 稅後淨利 | −3.2M-11% | −4.6M-2% | −4.8M-37% | −4.3M-20% | −3.6M-56% | −4.6M-56% | −7.6M-25% | −5.4M-25% | −8.1M | −10.7M | −10.2M | −7.2M |
| 淨利率 | -26.0% | -41.1% | -47.7% | -41.0% | -34.7% | -47.4% | -79.0% | -55.8% | -87.2% | -135.5% | -124.3% | -62.1% |
| 稀釋 EPS | -0.06-14% | -0.08-11% | -0.08-47% | -0.08-38% | -0.07-65% | -0.09-65% | -0.15-56% | -0.13-48% | -0.20 | -0.26 | -0.34 | -0.25 |
| 稀釋股數 | 53.6M | 53.6M | 53.5M | 53.5M | 53.4M | 53.4M | 51.8M | 40.9M | 40.8M | 31.8M | 30.0M | 28.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 6.0M | 4.3M | 5.9M | 3.2M | 3.3M | 3.4M | 6.1M | 18.6M | 21.6M | 28.5M | 32.1M | 23.7M |
| 應收帳款 | 5.4M | 5.7M | 4.6M | 5.1M | 5.1M | 5.6M | 4.6M | 4.6M | 4.6M | 3.9M | 5.2M | 4.6M |
| 存貨 | 6.9M | 6.9M | 7.1M | 6.9M | 7.6M | 6.6M | 7.7M | 11.0M | 11.2M | 11.6M | 11.5M | 12.0M |
| 總資產 | 95.9M | 98.7M | 104M | 108M | 110M | 114M | 124M | 115M | 121M | 129M | 138M | 133M |
| 有息負債 | 13.2M | 13.2M | 13.1M | 13.1M | 13.0M | 13.0M | 10.9M | 12.3M | 13.2M | 13.3M | 13.2M | 0.00 |
| 總負債 | 33.3M | 33.7M | 34.8M | 35.0M | 34.4M | 35.4M | 36.8M | 36.4M | 37.4M | 38.6M | 38.7M | 46.3M |
| 股東權益 | 62.6M | 64.9M | 68.8M | 72.7M | 76.1M | 78.6M | 87.3M | 78.9M | 83.4M | 90.0M | 99.7M | 86.2M |
| 負債比 | 34.7% | 34.2% | 33.6% | 32.5% | 31.2% | 31.0% | 29.7% | 31.6% | 31.0% | 30.0% | 28.0% | 35.0% |
| 淨現金(現金 − 有息負債) | −7.2M | −8.9M | −7.2M | −9.9M | −9.8M | −9.6M | −4.7M | 6.3M | 8.4M | 15.2M | 18.9M | 23.7M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.4M-18% | – | – | – | −4.1M | – | – | −6.6M | – | – | – |
| 資本支出 | – | 221K | – | – | – | 206K | – | – | 112K | – | – | – |
| 自由現金流 | – | −3.6M-17% | – | – | – | −4.3M | – | – | −6.7M | – | – | – |
| 折舊攤銷 | – | 1.6M | – | – | – | 1.6M | – | – | 1.6M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -32.3% | – | – | – | -44.0% | – | – | -71.8% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 40.5M
| 美國 | 38.2M | 94.4% | +6.5% |
|---|---|---|---|
| 美國以外 | 2.3M | 5.6% | +24.4% |
產品／服務2025 年度 · 40.5M
| Lab Essentials | 31.0M | 76.6% | +7.5% |
|---|---|---|---|
| Clinical Solutions | 7.7M | 18.9% | +7.8% |
| Other Product | 1.8M | 4.5% | +3.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 40.5M | +7.4% | −17.3M | -42.6% | -0.32 | −9.8M |
| FY2024 | 37.7M | +2.9% | −26.7M | -70.9% | -0.57 | −13.5M |
| FY2023 | 36.7M | -11.4% | −36.8M | -100.3% | -1.16 | −26.7M |
| FY2022 | 41.4M | +12.3% | −47.5M | -114.6% | -1.69 | −55.5M |
| FY2021 | 36.9M | +17.9% | −9.8M | -26.6% | -0.61 | −28.9M |
| FY2020 | 31.3M | – | 3.6M | 11.4% | 0.16 | −3.0M |